Hua Gong

Company: ZaiLaboratory

Job title: SVP, Translational Medicine and Clinical Biomarker

Seminars:

Panel Discussion: Balancing Novel Biomarkers for Multiple Cancer Types for DDR Inhibitor Development 12:00 pm

• Can we repurpose biomarkers used by other areas of oncology? • What do we need to know to develop and validate biomarkers amongst the complexity of DDR pathways? • Are novel target specific biomarkers for every novel target a worthwhile pursuit or realistic goal? Should we aim for a universal DDR biomarker?Read more

day: Pre-Conference Day

Maximizing Specificity of Biomarkers for Novel DDR Inhibitor Target Engagement 9:30 am

• Benchmark the validity of existing biomarkers of cell stress and broad deficiencies in DDR for the development of the next wave of DDR inhibitors • Explore development of biomarkers for specific targets in DDR pathways based on differential biology between targets • Assess the current landscape of unique biomarkers that discriminate between highly diverse…Read more

day: Pre-Conference Day